7,614 results match your criteria Radiation Therapy in Gynecology


Fertility Preservation for Adolescents Receiving Cancer Therapies.

Authors:
Leslie C Appiah

Clin Obstet Gynecol 2020 Jul 8. Epub 2020 Jul 8.

Division Chief of General Obstetrics and Gynecology, Department of Obstetrics and Gynecology, University of Colorado Denver.

According to the National Cancer Institute, ∼300,000 children globally are diagnosed with cancer each year. Advancements in chemotherapy and radiotherapy have revolutionized cancer treatment and improved long-term survival. Although many survivors will remain in good health with disease-free prognoses, three fourths will experience short-term and long-term effects from treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GRF.0000000000000547DOI Listing

Role of adjuvant therapy in stage IIIC2 endometrial cancer.

Int J Gynecol Cancer 2020 Jul 9. Epub 2020 Jul 9.

Division of Gynecologic Oncology, Mayo Clinic Rochester, Rochester, Minnesota, USA

Objective: The role of the different types of adjuvant treatments in endometrial cancer with para-aortic node metastases is unclear. The aim of this study was to report oncologic outcomes after adjuvant therapy in patients with stage IIIC2 endometrial cancer.

Methods: This retrospective single-institution study assessed patients with stage IIIC2 endometrial cancer who underwent primary surgery from January 1984 to December 2014. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2020-001446DOI Listing

Outcome patterns of cervical adenocarcinoma and squamous cell carcinoma following curative surgery: before and after propensity score matching analysis of a cohort study.

Am J Cancer Res 2020 1;10(6):1793-1807. Epub 2020 Jun 1.

Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital Yilan, Taiwan.

To estimate the outcome patterns and predictors of curative surgery for cervical squamous cell carcinoma (SCC) and adenocarcinoma (ADC) for overall survival (OS), locoregional recurrence (LRR), and distant metastasis (DM), we enrolled 4628 patients who had received a diagnosis of cervical SCC or ADC and received curative surgery. Cox regression analysis was employed to calculate hazard ratios and confidence intervals (CIs); independent predictors were controlled for or stratified in the analysis, and the endpoint was all-cause death. Propensity score matching was conducted to create well-balanced groups. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339276PMC

Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.

Aging (Albany NY) 2020 Jul 7;12. Epub 2020 Jul 7.

Department of Plastic Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou Zhejiang, P.R. China.

Skin cutaneous melanoma (SKCM) is characterized by both epigenetic DNA methylation (MET) abnormalities and genomic copy number variations (CNVs). The resulting transcriptome dysregulation promotes progression of many cancers. In this study, DNA copy numbers and MET, as well as mRNA expression, were examined in 466 SKCM samples from The Cancer Genome Atlas. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/aging.103115DOI Listing

Clitoral metastasis from uterine cervical cancer: A case report and review of the literature.

Gynecol Oncol Rep 2020 Aug 8;33:100591. Epub 2020 Jun 8.

Department of Obstetrics and Gynecology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.

A 81-year-old woman vaginal bleeding and vulvar pain. Pretreatment work-up revealed a 4.5 cm cervical cancer extended to the lower-third of the vagina and an isolated clitoral metastasis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2020.100591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327413PMC

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial.

Ann Oncol 2020 Jul 4. Epub 2020 Jul 4.

Department of Medical Oncology, Guy's Hospital and Sarah Cannon Research Institute, London, UK.

Background: Patients with brain metastases (BM) from human epidermal growth factor receptor 2 (HER2)-positive breast cancer represent a difficult-to-treat population. Trastuzumab emtansine (T-DM1) has shown potential activity in this subset of patients in small clinical series.

Patients And Methods: KAMILLA is an ongoing, phase IIIb study of T-DM1 in patients with HER2-positive locally advanced/metastatic breast cancer (MBC) with prior HER2-targeted therapy and chemotherapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annonc.2020.06.020DOI Listing

FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era.

Cancers (Basel) 2020 Jul 2;12(7). Epub 2020 Jul 2.

Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan.

Recent widespread use of three-dimensional image-guided brachytherapy (3D-IGBT) has improved radiotherapy outcomes of cervical cancer dramatically. In 2018, the International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical cancer was revised. However, the influence of the revisions on the stage distribution and outcomes of cervical cancers treated with 3D-IGBT remains unclear. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12071770DOI Listing

Sustained Adrenergic Activation of YAP1 Induces Anoikis Resistance in Cervical Cancer Cells.

iScience 2020 Jun 20;23(7):101289. Epub 2020 Jun 20.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

Chronic stress-related hormones modulate tumor pathogenesis at multiple levels; however, the molecular pathways involved in stress and cervical cancer progression are not well understood. We established a preclinical orthotopic mouse model of cervical cancer and used the model to show that daily restraint stress increased tumor growth and metastatic tumor burden. Exposure to norepinephrine significantly protected cervical cancer cells from anoikis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.isci.2020.101289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334594PMC

Pembrolizumab and Radiotherapy for Platinum-refractory Recurrent Uterine Carcinosarcoma With an Abscopal Effect: A Case Report.

Anticancer Res 2020 Jul;40(7):4131-4135

Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan.

Background: Immune responses due to radiotherapy and immune checkpoint inhibitors potentially have synergistic effects.

Case Report: Here, we report a 65-year-old Japanese woman presenting with high-grade endometrial cancer. She was diagnosed with carcinosarcoma, stage IB. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.14412DOI Listing

Hysterectomy for Recurrent/Residual Cervical Cancer Following Definitive Radiotherapy.

In Vivo 2020 Jul-Aug;34(4):2173-2177

Department of Obstetrics and Gynecology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.

Background/aim: Radical hysterectomy has been used for local recurrent or persistent (LR) cervical cancer after radiotherapy (RT), but the rate of serious complications is high and tolerance is low. This study determined the efficacy, safety, and prognostic factors of adjuvant simple hysterectomy in LR cervical cancer post-RT.

Patients And Methods: A total of 21 patients who underwent hysterectomy for LR cervical cancer post-RT in our Department between May 2007 and September 2018 were included in the study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/invivo.12026DOI Listing

Squamous Cell Carcinoma from Abscessed, Mature Cystic Ovarian Teratoma - A Case Report and Literature Review.

In Vivo 2020 Jul-Aug;34(4):2141-2146

Department of Surgery, "Ponderas" Academic Hospital, Bucharest, Romania.

Background/aim: Malignant transformation of mature cystic ovarian teratoma is a scarce eventuality, only rare cases being reported so far. Furthermore, development of this transformation in the setting of an abscessed tumor is even scarcer. The aim of this study was to report the case of a 47-year-old patient submitted to surgery for such a lesion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/invivo.12020DOI Listing

Management options for Vaginal Intraepithelial Neoplasia.

Int J Clin Pract 2020 Jun 29:e13598. Epub 2020 Jun 29.

1stdepartment of Obstetrics and Gynecology, Attikon Hospital, National and Kapodistrian University of Athens, Athinon, Greece.

Background: Vaginal intraepithelial neoplasia (VaIN) is a rare disease of the lower genital tract, strongly associated with HPV infection, which may progress to vaginal carcinoma.

Purpose: The aim of this review is to summarize current treatment options, evaluate their efficacy, and make provide recommendations on the optimal management of the disease.

Materials And Methods: A comprehensive search of the literature was performed using the PubMed database for articles referring to the treatment of VaIN. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijcp.13598DOI Listing

Ductal Carcinoma In Situ of the Breast: Perspectives on Tumor Subtype and Treatment.

Biomed Res Int 2020 27;2020:7251431. Epub 2020 May 27.

Institute of Pathology, China Three Gorges University, Yichang 443000, China.

Objective: To evaluate ductal carcinoma in situ (DCIS) characteristics and the effect of different treatment strategies. . Using data with known hormone receptor (HoR) and human epidermal growth factor receptor 2 (HER2) status obtained by the Surveillance, Epidemiology, and End Results (SEER) program from 2010-2014, the study was conducted to investigate tumor subtype-specific differences in various characteristics, overall survival (OS), and breast cancer-specific mortality (BCSM). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2020/7251431DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275239PMC

Efficacy and toxicity of postoperative external beam radiotherapy or chemoradiation for early-stage cervical cancer.

Int J Gynecol Cancer 2020 Jun 25. Epub 2020 Jun 25.

Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.

Objective: The aim of this study was to assess the impact of the evolving role of the addition of chemotherapy to postoperative radiotherapy on oncological outcomes and toxicity in patients with early-stage cervical cancer after radical hysterectomy.

Methods: Retrospective cohort study of patients with stage IB1-IIB FIGO 2009 cervical cancer treated from November 1999 to May 2015 by primary surgery and radiotherapy (46-50.4 Gy in 1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2019-001131DOI Listing

Plasma lncRNA FEZF1-AS1 as a potential biomarker for diagnosis of non-small-cell lung carcinoma.

Medicine (Baltimore) 2020 Jun;99(26):e21019

Department of Medical Oncology, The Fourth Hospital of Hebei Medical University.

Diagnosis of numerous cancers has been closely linked to the expression of certain long non-coding RNAs. This study aimed to evaluate levels of plasma FEZ family zinc finger 1 antisense RNA 1 (FEZF1-AS1) relative to non-small-cell lung carcinoma (NSCLC) diagnosis.The level of FEZF1-AS1 in the blood plasma of 126 NSCLC patients and 62 healthy controls was examined by quantitative real-time polymerase chain reaction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000021019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329120PMC
June 2020
5.723 Impact Factor

An Innovative Therapeutic Option for the Treatment of Skeletal Sarcomas: Elimination of Osteo- and Ewing's Sarcoma Cells Using Physical Gas Plasma.

Int J Mol Sci 2020 Jun 23;21(12). Epub 2020 Jun 23.

Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Osteosarcoma and Ewing's sarcoma are the most common malignant bone tumors. Conventional therapies such as polychemotherapy, local surgery, and radiotherapy improve the clinical outcome for patients. However, they are accompanied by acute and chronic side effects that affect the quality of life of patients, motivating novel research lines on therapeutic options for the treatment of sarcomas. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21124460DOI Listing

Differences in Treatment Outcomes and Prognosis between Elderly and Younger Patients Receiving Definitive Radiotherapy for Cervical Cancer.

Int J Environ Res Public Health 2020 Jun 23;17(12). Epub 2020 Jun 23.

Department of Radiation Oncology, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan.

The aim was to compare the clinical outcomes and prognostic factors of cervical cancer between elderly and younger women, and to explore which treatment strategy is more appropriate for elderly patients. We retrospectively reviewed patients with cervical cancer receiving definitive radiotherapy (RT) between 2007 and 2016, and divided them into two age groups: age < 70 vs. age ≥ 70. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijerph17124510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345764PMC

Alisol A is potentially therapeutic in human breast cancer cells.

Oncol Rep 2020 Jun 22. Epub 2020 Jun 22.

Peking University Third Hospital, Department of General Surgery, Beijing 100191, P.R. China.

Recent developments in breast cancer therapy have significantly improved patient survival rate; however, recurrence remains a major problem. Systemic treatment of breast cancer with available therapies is not curative. Natural products can be potentially used for treating cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2020.7654DOI Listing

Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer.

Jpn J Clin Oncol 2020 Jun 24. Epub 2020 Jun 24.

Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Objective: This study investigated the effect of para-aortic lymph node sampling or dissection in recently revised International Federation of Gynecology and Obstetrics IIIC1p cervical cancer treated with primary surgery and adjuvant radiation therapy with concurrent chemotherapy.

Methods: We retrospectively reviewed the records of 343 patients with early-stage cervical cancer and pathologically proven pelvic lymph node metastasis following curative surgery from 2001 to 2014. No patient had imaging evidence of para-aortic lymph node involvement, and all patients received adjuvant concurrent chemotherapy with or without concurrent chemotherapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyaa091DOI Listing

COVID-19 and gynecological cancer: a review of the published guidelines.

Int J Gynecol Cancer 2020 Jun 23. Epub 2020 Jun 23.

Department of Oncology, University of Surrey, Guildford, United Kingdom.

On March 11, 2020 the COVID-19 outbreak was declared a 'pandemic' by the World Health Organization. COVID-19 is associated with higher surgical morbidity and mortality. An array of guidelines on the management of cancer during this pandemic have been published since the first reports of the outbreak. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2020-001634DOI Listing

HS2ST1-dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior.

Cancer Sci 2020 Jun 23. Epub 2020 Jun 23.

Department of Gynecology and Obstetrics, Münster University Hospital, Münster, Germany.

Heparan sulfate proteoglycans (HSPGs) act as signaling co-receptors by interaction of their sulfated glycosaminoglycan chains with numerous signaling molecules. In breast cancer, the function of heparan sulfate 2-O-sulfotransferase (HS2ST1), the enzyme mediating 2-O-sulfation of HS, is largely unknown. Hence, a comparative study on the functional consequences of HS2ST1 overexpression and siRNA knockdown was performed in the breast cancer cell lines MCF-7 and MDA-MB-231. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.14539DOI Listing

Treatment with flow diverter stent during pregnancy.

Neuroradiology 2020 Jun 22. Epub 2020 Jun 22.

Interventional Neuroradiology Department, Strasbourg University Hospitals, Strasbourg, France.

Intracranial aneurysms are rarely diagnosed during pregnancy. If treatment is necessary, surgery was traditionally preferred over embolization in case of ongoing pregnancy, due to concerns regarding foetal radiation exposure. We present a case of 21 mm unruptured carotid-ophthalmic aneurysm diagnosed during pregnancy and treated with flow diversion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00234-020-02474-0DOI Listing

Prognostic factors in patients with vulvar cancer: the VULCAN study.

Int J Gynecol Cancer 2020 Jun 22. Epub 2020 Jun 22.

Gynecologic Oncology Department, Riga East Clinical University Hospital Latvian Oncology Center, Riga, Latvia.

Objective: This study aimed to analyze the prognostic factors for overall and progression-free survival in patients with vulvar cancer.

Methods: This international, multicenter, retrospective study included 2453 patients diagnosed with vulvar cancer at 100 different institutions. Inclusion criteria were institutional review board approval from each collaborating center, pathologic diagnosis of invasive carcinoma of the vulva, and primary treatment performed at the participating center. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2019-000526DOI Listing

PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancer.

Oncol Lett 2020 Jul 14;20(1):581-588. Epub 2020 May 14.

Department of Gynecology and Obstetrics, Evangelisches Krankenhaus Bethel, D-33617 Bielefeld, Germany.

In the current retrospective cohort study, the expression of the Proteasome 26S non-ATPase Subunit 9 (PSMD9) was investigated in 102 patients with cervical cancer. The rat homologue of PSMD9, Bridge-1, was identified as a binding protein of the transcription factors PDX-1 and E-12 via its PDZ-domain. The aim of the current study was to evaluate the prognostic or predictive value of PSMD9 expression as a biomarker for patients with cervical cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2020.11622DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285846PMC

Zambia's National Cancer Centre response to the COVID-19 pandemic-an opportunity for improved care.

Ecancermedicalscience 2020 28;14:1051. Epub 2020 May 28.

Department of Oncology, Cancer Diseases Hospital, Lusaka 10101, Zambia.

The COVID-19 pandemic has overwhelmed health systems around the globe even in countries with strong economies. This is of particular concern for nations with weaker health systems. This article reports the response of a comprehensive cancer centre in a lower-middle income country to prevent COVID-19 transmission and how the implementation of pragmatic strategies have served as a springboard to improve cancer services beyond the COVID-19 pandemic. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2020.1051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289614PMC

Cervical carcinoma in the setting of uterovaginal prolapse: comparing standard versus tailored management.

Ecancermedicalscience 2020 13;14:1043. Epub 2020 May 13.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY 10065, USA.

Objectives: Cervical cancer in the setting of uterovaginal prolapse is exceedingly rare. Altered anatomy can complicate treatment of underlying cancer. We first present a rare case of cervical cancer with invasion of uterovaginal prolapse as well as a systematic review of similar reported cases in the literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2020.1043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289612PMC

Biocurcumin as Radiosensitiser for Cervical Cancer Study (BRACES): A Double-Blind Randomised Placebo-Controlled Trial.

Evid Based Complement Alternat Med 2020 28;2020:1986793. Epub 2020 May 28.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.

Cervical cancer is a leading cause of death among women worldwide, particularly in Indonesia. The main treatment of advanced-stage cervical cancer is radiation; however, the outcomes do not meet the required expectations. [1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5dione] has been reported in several studies for its potency in cancer therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2020/1986793DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275233PMC

Fertility preservation in women with early-stage gynecologic cancer: optimizing oncologic and reproductive outcomes.

Int J Gynecol Cancer 2020 Jun 21. Epub 2020 Jun 21.

Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Baylor College of Medicine, Houston, TX, United States

Almost all standard therapies for gynecologic cancer, including surgical intervention, gonadotoxic chemotherapy, and radiation therapy, threaten a woman's childbearing potential. Preservation of fertility should be discussed with premenopausal women with early-stage gynecologic cancer shortly after diagnosis and, for women who desire to preserve fertility, during treatment planning. Many authors have investigated both oncologic and reproductive outcomes following fertility-sparing therapy, and there is ongoing development of assisted reproduction techniques available to cancer patients and survivors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2020-001328DOI Listing

ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer.

DNA Cell Biol 2020 Jun 16. Epub 2020 Jun 16.

Department of Radiotherapy, People's Hospital of Shanxi Province, Taiyuan, China.

Annexin A4 (encoded by the gene) is a calcium ion (Ca)- and phospholipid-binding protein of the Annexin family. In this study, we checked the expression profile of in basal-like breast cancer (BLBC) and its association with survival outcomes using pan-cancer data from The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) project. Then, using MDA-MB-231 and MDA-MB-468 cells, we explored the functional role of ANXA4 in regulating a cancer-related signaling pathway and identified potential partners of ANXA4. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/dna.2020.5570DOI Listing
June 2020
2.055 Impact Factor

Retinoblastoma protein expression and its predictors in triple-negative breast cancer.

NPJ Breast Cancer 2020 5;6:19. Epub 2020 Jun 5.

Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA USA.

Retinoblastoma protein (Rb) is a product of the tumor suppressor gene. Its expression is highly prevalent in luminal breast cancers and is critical to the success of cyclin-dependent kinase (CDK) 4/6 inhibitor therapy. Expression of Rb in triple-negative breast cancer (TNBC), tumors generally associated with basal biology, is not well known. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-020-0160-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275038PMC

Tumor circulome in the liquid biopsies for digestive tract cancer diagnosis and prognosis.

World J Clin Cases 2020 Jun;8(11):2066-2080

Department of Gynecology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang Province, China.

Digestive tract cancer is one of the main diseases that endanger human health. At present, the early diagnosis of digestive tract tumors mainly depends on serology, imaging, endoscopy, and so on. Although tissue specimens are the gold standard for cancer diagnosis, with the rapid development of precision medicine in cancer, the demand for dynamic monitoring of tumor molecular characteristics has increased. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12998/wjcc.v8.i11.2066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281040PMC

Prediction scoring system based on clinicohematologic parameters for cervical cancer patients undergoing chemoradiation.

Int J Gynecol Cancer 2020 Jun 16. Epub 2020 Jun 16.

Department of Radiation Oncology, Gachon University Gil Medical Center, Incheon, Republic of Korea

Objective: A scoring system based on clinicohematologic parameters in cervical cancer patients receiving chemoradiation has not been reported to date. The aim of this study was to determine the prognostic value of clinicohematologic parameters in patients with cervical cancer undergoing chemoradiation and to develop a prediction scoring system based on these results.

Methods: A total of 107 patients who received definitive chemoradiation for cervical cancer were enrolled in this study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2019-001050DOI Listing

The outcomes and quality of life of young patients undergoing adjuvant radiotherapy versus non-radiotherapy following surgery treating early FIGO stage cervical squamous cell cancer in southwestern China.

Sci Rep 2020 Jun 12;10(1):9583. Epub 2020 Jun 12.

Department of Obstetrics and Gynecology, West China Second University Hospital, Chengdu, China.

Background: The incidence of cervical cancer in young women is rising, and squamous cell carcinoma makes up a great percentage of the histological types. The presence of aggressive pathologic risk factors following patients' primary surgery may warrant the use of adjuvant radiotherapy. It is important to weigh up the risks and benefits of using adjuvant radiotherapy for each young patient so as to maximize their prognosis while minimizing the treatment-related morbidity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-020-66661-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293287PMC

Impact of Adjuvant Radiation Therapy in Patients With Male Breast Cancer: A Multicenter International Analysis.

Adv Radiat Oncol 2020 May-Jun;5(3):345-349. Epub 2020 Feb 20.

Department of Radiotherapy and Radiation Oncology, Franziskus Hospital Bielefeld, Bielefeld, Germany.

Purpose: Breast cancer in men accounts for approximately 1% of all breast cancers. Breast cancer trials have routinely excluded men. The aim of this analysis was to determine the effect of different treatment factors, in particular, postoperative radiation therapy (RT) on long-term outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.adro.2020.01.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276673PMC
February 2020

Impact of mobile technologies on cervical cancer screening practices in Lagos, Nigeria (mHealth-Cervix): Protocol for a randomised controlled trial.

F1000Res 2020 4;9:322. Epub 2020 May 4.

Stanford Women's Cancer Center, Stanford Cancer Institute, Stanford University School of Medicine, Palo Alto, California, 94304, USA.

Incidence and mortality from cervical cancer have remained high due to many obstacles facing the implementation of organized screening programs in resource-constrained countries such as Nigeria. The application of mobile technologies (mHealth) to health services delivery has the potential to reduce inequalities, empower patients to control their health, and improve the cost-effectiveness of health care delivery. To assess the efficacy of mobile technology intervention on Pap test screening adherence compared to a control condition and also determine the factors affecting the uptake of Pap smear screening practices among women in Lagos. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.22991.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265590PMC

Good news on the active management of pregnant cancer patients.

F1000Res 2020 1;9. Epub 2020 Jun 1.

Department of Obstetrics and Gynecology, Northwestern University, 250 East Superior Street, Suite 03-2303, Chicago, IL, 60611, USA.

Cancer occurs in approximately 1/1000 to 1/2000 pregnancies and presents complex medical and ethical dilemmas for patients and providers. The most common cancers diagnosed in the gestational period include breast, cervical, melanoma, and lymphomas. The majority of existing evidence regarding the treatment of cancer during pregnancy is derived from experiences with breast cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.22472.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265588PMC

Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.

Int J Gynecol Cancer 2020 Jun 11. Epub 2020 Jun 11.

Radiation Oncology, Washington University School of Medicine, St Louis, Missouri, USA

Objective: Compared with 3D-planned pelvic radiation, intensity-modulated radiation therapy (IMRT) has been shown to reduce acute toxicity in cervical cancer patients after radical hysterectomy. This study evaluated late toxicity and patterns of failure after post-operative pelvic IMRT interdigitated weekly with high dose rate brachytherapy.

Methods: This retrospective study included 53 cervical cancer patients treated between January 2006 and August 2019 with radical hysterectomy, lymphadenectomy, and post-operative IMRT and high dose rate brachytherapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2020-001412DOI Listing

Uterine PEComa with aggressive behavior: A review with an additional case of spontaneous vaginal expulsion.

Pathol Res Pract 2020 Jun 4;216(6):152991. Epub 2020 May 4.

Pathology Unit, Service Department, ULSS9 "Scaligera", Verona, Italy. Electronic address:

Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal tumor originating from perivascular epitheloid cells showing melanocytic and smooth muscle differentiation. The uterus represents the second most common site of origin. A 49 years woman presented to our Hospital for a vaginal spontaneous expulsion of a mass suggestive for malignant mesenchymal tumor. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2020.152991DOI Listing

Anti-tumor activities of probiotics in cervical cancer.

J Ovarian Res 2020 Jun 11;13(1):68. Epub 2020 Jun 11.

Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, Iran.

Cervical cancer is considered as an important malignancy among women worldwide. Currently-used treatments of cervical cancer are reported to be cytotoxic for patients. Moreover, these therapies have shown some side effects which can negatively affect the lives of women suffering from this cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13048-020-00668-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291573PMC

Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.

Int J Gynaecol Obstet 2020 Jun 11. Epub 2020 Jun 11.

Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.

Objective: To determine the acceptance rate of treatment alternatives for women with either preinvasive conditions or gynecologic cancers during the COVID-19 pandemic among Latin American gynecological cancer specialists.

Methods: Twelve experts in gynecological cancer designed an electronic survey, according to recommendations from international societies, using an online platform. The survey included 22 questions on five topics: consultation care, preinvasive cervical pathology, and cervical, ovarian, and endometrial cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijgo.13272DOI Listing

Small-Cell Carcinoma of the Uterine Cervix Discovered With Quadriplegia Caused by Cervical Spine Metastasis.

Clin Med Insights Case Rep 2020 7;13:1179547620920170. Epub 2020 May 7.

Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan.

Small-cell carcinoma of the uterine cervix is a rare and aggressive tumor, and the prognosis is poor compared with those of squamous cell carcinoma and adenocarcinoma of the uterine cervix, even when discovered at an earlier stage. We treated a patient with progressive small-cell carcinoma of the uterine cervix that metastasized to the cervical spine. The patient, a 73-year-old woman, presented with the symptom of numbness in her limbs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1179547620920170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236087PMC

Leonurine Promotes Cisplatin Sensitivity in Human Cervical Cancer Cells Through Increasing Apoptosis and Inhibiting Drug-Resistant Proteins.

Drug Des Devel Ther 2020 15;14:1885-1895. Epub 2020 May 15.

Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, People's Republic of China.

Background: Cisplatin-based neoadjuvant chemotherapy and concurrent radiotherapy and chemotherapy are the main treatment for advanced cervical cancer. However, the development of multidrug resistance (MDR) leads to chemotherapy failure, tumor recurrence and poor survival. In this research, we investigated the effect and corresponding mechanism of leonurine on cisplatin sensitivity of cervical cancer cells. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S252112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237110PMC

Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer: the CSEM 006 study.

Int J Gynecol Cancer 2020 Jun 9. Epub 2020 Jun 9.

Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

Background: Concurrent chemoradiotherapy is the first-line treatment for FIGO stage IIB cervical cancer. Neoadjuvant chemotherapy followed by radical surgery may provide another treatment option.

Primary Objective: To compare the therapeutic outcomes of neoadjuvant chemotherapy followed by surgery with cisplatin-based concurrent chemoradiotherapy for stage IIB cervical cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2020-001357DOI Listing

Chromatin Trapping of Factors Involved in DNA Replication and Repair Underlies Heat-Induced Radio- and Chemosensitization.

Cells 2020 Jun 8;9(6). Epub 2020 Jun 8.

Institute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.

Hyperthermia has been used as an adjuvant treatment for radio- and chemotherapy for decades. In addition to its effects on perfusion and oxygenation of cancer tissues, hyperthermia can enhance the efficacy of DNA-damaging treatments such as radiotherapy and chemotherapy. Although it is believed that the adjuvant effects are based on hyperthermia-induced dysfunction of DNA repair systems, the mechanisms of these dysfunctions remain elusive. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells9061423DOI Listing

Flavonoids in Cancer Metastasis.

Cancers (Basel) 2020 Jun 8;12(6). Epub 2020 Jun 8.

Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 03601 Martin, Slovakia.

Metastasis represents a serious complication in the treatment of cancer. Flavonoids are plant secondary metabolites exerting various health beneficiary effects. The effects of flavonoids against cancer are associated not only with early stages of the cancer process, but also with cancer progression and spread into distant sites. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12061498DOI Listing

AMTRA: a multicentered experience of a web-based monitoring and tailored toxicity management system for cancer patients.

Support Care Cancer 2020 Jun 9. Epub 2020 Jun 9.

Department of Oncology, Multidisciplinary Oncological Center Antwerp, MOCA, University Hospital Antwerp, Wilrijkstraat 10, 2650, Edegem, Belgium.

Background: Technology-based interventions are increasingly being introduced in routine clinical cancer care. There is a need for reliable systems to monitor treatment-related toxicity in a standardized manner. Such electronic tools bridge the gap in providing quality home-based monitoring. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-020-05550-6DOI Listing

Expression of immune cell markers and tumor markers in patients with cervical cancer.

Int J Gynecol Cancer 2020 Jul 8;30(7):969-974. Epub 2020 Jun 8.

Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China

Objective: Cervical cancer is one of the most common cancers worldwide, and immune function may impact disease progression. Serum markers may also be associated with diagnosis and progression. The aim of this study was to explore the clinical usefulness of determining the levels of peripheral blood immune cells and serum tumor markers in predicting diagnosis and prognosis of patients with cervical cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2020-001254DOI Listing

Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer.

Target Oncol 2020 Jun 8. Epub 2020 Jun 8.

National Center for Tumor Diseases, University Hospital Heidelberg, German Cancer Research Center, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.

Triple-negative breast cancer constitutes ~ 15% of all breast cancer subtypes. Because of the negative hormone receptor and human epidermal growth factor receptor 2 status, therapy is mainly based on chemotherapy with a poor median overall survival in the metastatic setting of ~ 18 months. Compared to other breast cancer subtypes, triple-negative breast cancer is characterized by a higher mutational load, which renders the tumor immunogenic and amenable to immunotherapeutic intervention. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-020-00730-0DOI Listing

Intrauterine infusion of platelet-rich plasma for severe Asherman syndrome: a cutting-edge approach.

Updates Surg 2020 Jun 8. Epub 2020 Jun 8.

Department of Obstetrics and Gynecology, "Filippo Del Ponte" Hospital, University of Insubria, Varese, Italy.

Asherman syndrome (AS) consists of intrauterine adhesions development as a consequence of trauma, radiation, or infection in the endometrium. Clinical symptoms include menstrual alterations, infertility, and pregnancy complications, such as recurrent pregnancy loss or abnormal placentation. In this article, we performed a narrative review of the literature, searching electronic databases (i. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13304-020-00828-0DOI Listing